Wall Street changes its mind on these healthcare stocks. Why we were always optimistic
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Biotechnology and pharmaceuticals
Novo Nordisk and Eli Lilly address supply issues
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
CEOs of Merck, J&J and Bristol Myers Squibb face Senate hearing on drug prices
Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey about issuing subpoenas for drug company CEOs…
CVS Heath (CVS) Q4 2023 Earnings
A CVS location in New York, US, on Thursday, February 9, 2023. Stephanie Keith | Bloomberg | fake images CVS…
Novo Nordisk and Eli Lilly Address Weight Loss Drug Supply Issues
Good afternoon! All eyes are once again on Novo Nordisk and Eli Lilly as Wall Street looks for signs they…
Eli Lilly's Weight Loss Drug May Treat Fatty Liver Disease
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
Eli Lilly (LLY) Q4 2023 Earnings
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, U.S., on September 17,…
Novo Nordisk's parent company will buy Catalent to expand Wegovy supply
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
J&J, Merck and Bristol Myers Squibb on the bench
Do you think a friend or colleague should receive this newsletter? Share this link with them to register. Good afternoon!…
Non-opioid pain reliever Vertex shows positive results in late-stage trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston on Oct. 23, 2019. Brian Snyder | Reuters…